Krishna Rocha-Singh

Summary

Affiliation: Southern Illinois University
Country: USA

Publications

  1. ncbi Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial
    Krishna J Rocha-Singh
    Prairie Education and Research Cooperative, St John s Hospital, Springfield, IL, USA
    Catheter Cardiovasc Interv 80:1042-51. 2012
  2. ncbi Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis
    Krishna J Rocha-Singh
    Prairie Education and Research Cooperative, Springfield, Illinois 62794 9420, USA
    Catheter Cardiovasc Interv 78:779-89. 2011
  3. ncbi Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial
    Krishna Rocha-Singh
    Prairie Vascular Institute, Springfield, Illionis 62719, USA
    Catheter Cardiovasc Interv 72:853-62. 2008
  4. ncbi Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease
    Krishna J Rocha-Singh
    Prairie Vascular Institute, Springfield, Illinois 62794 9420, USA
    Catheter Cardiovasc Interv 69:910-9. 2007
  5. ncbi Percutaneous renal artery intervention for preservation of renal function: strategies for identification of "at-risk" patients
    Krishna Rocha-Singh
    Prairie Vascular Institute, Springfield, Illinois, USA
    Catheter Cardiovasc Interv 68:507-12. 2006
  6. ncbi Glycoprotein IIb-IIIa receptor inhibition with eptifibatide in percutaneous intervention for symptomatic peripheral vascular disease: the circulate pilot trial
    Krishna J Rocha-Singh
    Vascular Medicine Program, Prairie Heart Institute, St John s Hospital, 619 East Mason Street, Suite 4P57, Springfield, IL 62701, USA
    Catheter Cardiovasc Interv 66:470-3. 2005
  7. ncbi Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study
    Krishna Rocha-Singh
    Vascular Medicine Program, Prairie Heart Institute, Springfield, Illinois 62794 9420, USA
    J Am Coll Cardiol 46:776-83. 2005
  8. ncbi Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis
    K J Rocha-Singh
    Prairie Heart Institute and Prairie Education and Research Cooperative, Springfield, Illinois, USA
    Catheter Cardiovasc Interv 47:167-72. 1999
  9. ncbi One-year clinical outcomes and relative costs of primary infarct artery stenting versus angioplasty following systemic thrombolysis for acute myocardial infarction
    K J Rocha-Singh
    Prairie Heart Institute at St John s Hospital, Springfield, Illinois 62794, USA
    Catheter Cardiovasc Interv 49:135-41. 2000
  10. ncbi Combined glycoprotein IIb/IIIa receptor inhibition and low-dose fibrinolysis for peripheral arterial thrombosis
    Krishna J Rocha-Singh
    Prairie Heart Institute, St John s Hospital and Prairie Education and Research Cooperative, Department of Cardiology, Southern Illinois University School of Medicine, Springfield, Illinois 62794, USA
    Catheter Cardiovasc Interv 55:457-60. 2002

Detail Information

Publications22

  1. ncbi Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial
    Krishna J Rocha-Singh
    Prairie Education and Research Cooperative, St John s Hospital, Springfield, IL, USA
    Catheter Cardiovasc Interv 80:1042-51. 2012
    ..We evaluated the safety and effectiveness of the Xpert™ self-expanding nitinol stent (Abbott Vascular, Redwood City, CA) in Rutherford Class 4-6 subjects with infrapopliteal lesions of 4-15 cm in length...
  2. ncbi Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis
    Krishna J Rocha-Singh
    Prairie Education and Research Cooperative, Springfield, Illinois 62794 9420, USA
    Catheter Cardiovasc Interv 78:779-89. 2011
    ..To provide safety and performance goals for prospective single-arm trials of bare metal renal artery stenting in patients with resistant hypertension associated with high grade atherosclerotic renal artery stenosis...
  3. ncbi Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial
    Krishna Rocha-Singh
    Prairie Vascular Institute, Springfield, Illionis 62719, USA
    Catheter Cardiovasc Interv 72:853-62. 2008
    ..The multicenter, single-arm RENAISSANCE trial evaluated outcomes in patients with progressive atherosclerotic renal artery stenosis (ARAS) treated with the Express Renal Premounted Stent System (Boston Scientific, Natick, MA)...
  4. ncbi Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease
    Krishna J Rocha-Singh
    Prairie Vascular Institute, Springfield, Illinois 62794 9420, USA
    Catheter Cardiovasc Interv 69:910-9. 2007
    ..This analysis proposes safety and performance goals for prospective single-arm trials of bare nitinol stents to treat patients with debilitating claudication associated with femoropopliteal (FP) atherosclerotic lesions...
  5. ncbi Percutaneous renal artery intervention for preservation of renal function: strategies for identification of "at-risk" patients
    Krishna Rocha-Singh
    Prairie Vascular Institute, Springfield, Illinois, USA
    Catheter Cardiovasc Interv 68:507-12. 2006
  6. ncbi Glycoprotein IIb-IIIa receptor inhibition with eptifibatide in percutaneous intervention for symptomatic peripheral vascular disease: the circulate pilot trial
    Krishna J Rocha-Singh
    Vascular Medicine Program, Prairie Heart Institute, St John s Hospital, 619 East Mason Street, Suite 4P57, Springfield, IL 62701, USA
    Catheter Cardiovasc Interv 66:470-3. 2005
    ..These results demonstrate that adjunctive use of eptifibatide during percutaneous peripheral intervention is safe and supports further studies to establish the potential efficacy of GP IIb-IIIa inhibitors in this setting...
  7. ncbi Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study
    Krishna Rocha-Singh
    Vascular Medicine Program, Prairie Heart Institute, Springfield, Illinois 62794 9420, USA
    J Am Coll Cardiol 46:776-83. 2005
    ..This study sought to define the safety and durability of renal stenting after suboptimal/failed renal artery angioplasty in patients with suspected renovascular hypertension...
  8. ncbi Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis
    K J Rocha-Singh
    Prairie Heart Institute and Prairie Education and Research Cooperative, Springfield, Illinois, USA
    Catheter Cardiovasc Interv 47:167-72. 1999
    ....
  9. ncbi One-year clinical outcomes and relative costs of primary infarct artery stenting versus angioplasty following systemic thrombolysis for acute myocardial infarction
    K J Rocha-Singh
    Prairie Heart Institute at St John s Hospital, Springfield, Illinois 62794, USA
    Catheter Cardiovasc Interv 49:135-41. 2000
    ..These findings have important clinical and economic implications in an increasingly cost-conscious health care environment. Cathet. Cardiovasc. Intervent. 49:135-141, 2000...
  10. ncbi Combined glycoprotein IIb/IIIa receptor inhibition and low-dose fibrinolysis for peripheral arterial thrombosis
    Krishna J Rocha-Singh
    Prairie Heart Institute, St John s Hospital and Prairie Education and Research Cooperative, Department of Cardiology, Southern Illinois University School of Medicine, Springfield, Illinois 62794, USA
    Catheter Cardiovasc Interv 55:457-60. 2002
    ..No patient required repeat endovascular or surgical revascularization during mean follow-up of 9.3 months. This promising new thrombolytic strategy for the treatment of peripheral arterial occlusive disease requires further study...
  11. ncbi Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy
    Krishna J Rocha-Singh
    Prairie Heart Institute at St John s Hospital and Prairie Education and Research Cooperative, Department of Cardiology, Southern Illinois University School of Medicine, Springfield, Illinois 62794, USA
    Catheter Cardiovasc Interv 57:135-41. 2002
    ..Renal stent revascularization should be considered a valid therapeutic option for the long-term treatment of ischemic nephropathy...
  12. ncbi Heparin-induced thrombocytopenia with thrombosis after endovascular aneurysm repair
    Raghu Kolluri
    Prairie Vascular Institute, Springfield, Illinois 62702, USA
    Vasc Endovascular Surg 43:89-92. 2009
    ..This underscores the importance of considering heparin-induced thrombocytopenia as a potential cause for postendovascular thrombotic complications in the patient who develops thrombocytopenia following this procedure...
  13. ncbi Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial
    Gary M Ansel
    Section of Cardiology, Riverside Methodist Hospital, Columbus, Ohio, USA
    Catheter Cardiovasc Interv 67:288-97. 2006
    ..To evaluate the effect of glycoprotein IIb/IIIa inhibition during nitinol stenting, of superficial femoral occlusive disease...
  14. ncbi Hope springs eternal: the unfulfilled promise of femoropopliteal stenting
    Krishna Rocha-Singh
    Catheter Cardiovasc Interv 56:450-1. 2002
  15. ncbi Femoropopliteal subintimal angioplasty and nitinol stenting: a marriage of technique and technology...but will it last?
    Krishna Rocha-Singh
    Catheter Cardiovasc Interv 65:544-6. 2005
  16. ncbi Renal and iliac artery stenting by interventional cardiologists and vascular surgeons: the Foundation to Advance Medical Education (FAME) initiative
    David R Holmes
    Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, Minn 55905, USA
    Am Heart J 149:883-7. 2005
    ..Programs such as the FAME initiative will grow in importance as new technologies continue to be introduced into medical practice and the need to train physicians in practice in their use expands...
  17. ncbi Embolic protection and platelet inhibition during renal artery stenting
    Christopher J Cooper
    Cardiovascular Division, University of Toledo, 3000 Arlington Ave, MS 1036, Toledo, OH 43614, USA
    Circulation 117:2752-60. 2008
    ..Although atheroembolization can cause renal dysfunction during renal stent procedures, whether adjunctive use of embolic protection devices or glycoprotein IIb/IIIa inhibitors improves renal function is unknown...
  18. ncbi Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease
    Paul Michael Grossman
    University of Michigan Healthcare System, Ann Arbor, MI 48109 0311, USA
    Am Heart J 153:874-80. 2007
    ....
  19. ncbi Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial
    Robert J Lederman
    Division of Cardiology, University of Michigan Health System, Ann Arbor, MI, USA
    Lancet 359:2053-8. 2002
    ..We investigated whether one or two doses of intra-arterial rFGF-2 improves exercise capacity in patients with moderate-to-severe intermittent claudication...
  20. ncbi The Barath cutting balloon: battling the sword of Damocles
    Krishna Rocha-Singh
    Catheter Cardiovasc Interv 56:232-3. 2002
  21. ncbi The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease
    John Spertus
    Mid America Heart Institute of Saint Luke s Hospital and the University of Missouri Kansas City, Kansas City, MO, USA
    Am Heart J 147:301-8. 2004
    ..The Peripheral Artery Questionnaire (PAQ) is a 20-item questionnaire developed to meet this need by quantifying patients' physical limitations, symptoms, social function, treatment satisfaction, and quality of life...
  22. ncbi Aortorenal artery translesion pressure gradients in renovascular hypertension: In search of clinical significance
    Krishna Rocha-Singh
    Catheter Cardiovasc Interv 59:378-9. 2003